On March 19, 2019, 19 ECHA Member States planned to evaluate 100 substances over the next three years. For the 31 substances specified for 2019, the evaluating authorities have 12 months from today to carry out their evaluations.
The primary purpose of the evaluation is to clarify whether further information is needed to conclude whether a substance poses a risk to humans or the environment. If necessary, the registrant is required to provide this information. Authorities assess suspicious issues and initiate regulatory risk management actions where relevant.
ECHA encourages registrants of listed substances to coordinate their actions and liaise with evaluating member states. Registrants are also urged to update their profiles, especially for purposes and risks and make comments before any decision to request further information. Member states and the ECHA will review the evaluating authorities draft decision before making a final decision.
These substances are assessed based on problems associated with their severe hazard characteristics. The substances may be suspected sensitizers, persistent, bioaccumulative and toxic (PBT) substances, carcinogenic, mutagenic and reprotoxic (CMR) substances or endocrine disruptors. The selection also considers wide dispersive worker or consumer use. The evaluation may also result in the identification of other concerns on the substances.